Impact of Different Pacing Sites on Pre‐Implantation Screening Test of Subcutaneous Implantable Cardioverter Defibrillators
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70216 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Youmei Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiac Pacing, Artificial, Electric Countershock, Arrhythmias, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Nanjing Medical University.
Abstract (Originalsprache)
Background
Pre‐implantation screening is a crucial step in preventing inappropriate sensing in patients with subcutaneous implantable cardioverter defibrillators (S‐ICDs). Paced QRS‐T morphology may influence screening outcomes. We aimed to explore the impact of pacing rhythm and different pacing sites on pre‐implantation screening of S‐ICD. Methods and Results This prospective, single‐center study enrolled patients referred for radiofrequency ablation, with both left and right‐heart access. A contact‐force ablation catheter was used to mimic ventricular pacing at different sites. Automatic screening tests for S‐ICD eligibility were performed during pacing and sinus rhythm. The impact of pacing sites on S‐ICD eligibility was assessed. Thirty patients (age 54.0 ± 15.0 years, 73.3% male) were enrolled. The overall passing rate during intrinsic sinus rhythm was 86.7%. Compared with sinus rhythm, conduction system pacing from His bundle or left bundle branch demonstrated comparable pass rates and the number of passed vectors, whereas right ventricular septum (RVS) pacing exhibited significantly lower pass rates and less pass vectors. Among all RVS pacing sites, the lowest pass rate was observed at the apical portion, followed by middle and basal portion ( p < 0.001 for all comparisons).
Conclusion
Conduction system pacing preserves patient eligibility for S‐ICD comparable to sinus rhythm, while RVS pacing significantly impairs sensing performance, with the greatest deterioration observed in apical pacing. These findings underscore the advantages of conduction system pacing in optimizing sensing function for patients eligible for both S‐ICDs and pacemakers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
- Division of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, China.
- Division of Cardiology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China.
ORCID-Profile: Hailei Liu, Linlin Wang, Mingfang Li, Minglong Chen
Förderung
- Nanjing Medical University
Zitieren
APA
Shen, Y., Ju, W., Chen, H., Liu, H., Wang, L., Jiang, X., Yang, G., Li, M., Gu, K., & Chen, M. (2026). Impact of Different Pacing Sites on Pre‐Implantation Screening Test of Subcutaneous Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70216
Vancouver
Shen Y, Ju W, Chen H, Liu H, Wang L, Jiang X, et al. Impact of Different Pacing Sites on Pre‐Implantation Screening Test of Subcutaneous Implantable Cardioverter Defibrillators. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70216
BibTeX
@article{Shen2026,
author = {Shen, Youmei and Ju, Weizhu and Chen, Hongwu and Liu, Hailei and Wang, Linlin and Jiang, Xiaohong and Yang, Gang and Li, Mingfang and Gu, Kai and Chen, Minglong},
title = {Impact of Different Pacing Sites on Pre‐Implantation Screening Test of Subcutaneous Implantable Cardioverter Defibrillators},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70216}
}
EUVIMED